| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.60B | 52.86B | 51.32B | 47.76B | 45.24B | 41.58B |
| Gross Profit | 32.34B | 33.18B | 32.60B | 29.53B | 29.51B | 27.50B |
| EBITDA | 7.91B | 7.75B | 9.11B | 7.80B | 9.63B | 9.60B |
| Net Income | 3.16B | 3.44B | 5.02B | 4.00B | 5.58B | 5.11B |
Balance Sheet | ||||||
| Total Assets | 55.96B | 57.80B | 58.90B | 53.39B | 52.76B | 48.24B |
| Cash, Cash Equivalents and Short-Term Investments | 11.73B | 11.82B | 13.83B | 11.34B | 12.30B | 13.55B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 8.48B | 8.74B | 10.08B | 7.46B | 8.77B | 8.04B |
| Stockholders Equity | 47.48B | 49.06B | 48.82B | 45.93B | 43.99B | 40.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.44B | 5.43B | 2.17B | 1.95B | 2.81B |
| Operating Cash Flow | 0.00 | 5.38B | 7.63B | 4.77B | 5.01B | 6.64B |
| Investing Cash Flow | 0.00 | -3.01B | -2.53B | -3.11B | -3.87B | -4.00B |
| Financing Cash Flow | 0.00 | -4.87B | -2.86B | -2.80B | -2.58B | -1.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥155.24B | 29.58 | ― | 5.00% | 1.41% | 0.75% | |
71 Outperform | ¥84.10B | 22.92 | 7.23% | 3.53% | 3.05% | -32.61% | |
70 Outperform | ¥2.72T | 24.05 | 11.50% | 2.41% | 4.62% | 47.68% | |
69 Neutral | ¥331.52B | 19.79 | 2.72% | 2.61% | 1.37% | -5.60% | |
63 Neutral | ¥138.78B | 62.64 | 3.10% | 1.45% | 3.95% | -25.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥1.17T | -22.37 | ― | 2.11% | -1.20% | -2896.72% |